nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—asthma—chronic obstructive pulmonary disease	0.185	1	CtDrD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.136	0.514	CiPCiCtD
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.129	0.486	CiPCiCtD
Methylprednisolone—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.103	1	CpDpCtD
Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.0939	0.506	CrCtD
Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.0917	0.494	CrCtD
Methylprednisolone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0202	0.259	CbGbCtD
Methylprednisolone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0191	0.244	CbGbCtD
Methylprednisolone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00836	0.107	CbGbCtD
Methylprednisolone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00565	0.0723	CbGbCtD
Methylprednisolone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00539	0.069	CbGbCtD
Methylprednisolone—Exemestane—Prednisone—chronic obstructive pulmonary disease	0.00507	0.0364	CrCrCtD
Methylprednisolone—Exemestane—Prednisolone—chronic obstructive pulmonary disease	0.00494	0.0355	CrCrCtD
Methylprednisolone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0048	0.0615	CbGbCtD
Methylprednisolone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0047	0.0602	CbGbCtD
Methylprednisolone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00444	0.0569	CbGbCtD
Methylprednisolone—Ciclesonide—Prednisone—chronic obstructive pulmonary disease	0.00337	0.0242	CrCrCtD
Methylprednisolone—Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.00329	0.0236	CrCrCtD
Methylprednisolone—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.00316	0.0227	CrCrCtD
Methylprednisolone—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.00294	0.0211	CrCrCtD
Methylprednisolone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.0361	CbGbCtD
Methylprednisolone—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.00282	0.0202	CrCrCtD
Methylprednisolone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.00275	0.0198	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.00273	0.0196	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.00266	0.0191	CrCrCtD
Methylprednisolone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00266	0.0341	CbGbCtD
Methylprednisolone—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00265	0.019	CrCrCtD
Methylprednisolone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.00265	0.019	CrCrCtD
Methylprednisolone—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00258	0.0186	CrCrCtD
Methylprednisolone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00258	0.0186	CrCrCtD
Methylprednisolone—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00258	0.0186	CrCrCtD
Methylprednisolone—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00257	0.0185	CrCrCtD
Methylprednisolone—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00251	0.018	CrCrCtD
Methylprednisolone—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.0025	0.018	CrCrCtD
Methylprednisolone—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00244	0.0175	CrCrCtD
Methylprednisolone—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00244	0.0175	CrCrCtD
Methylprednisolone—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00243	0.0175	CrCrCtD
Methylprednisolone—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00238	0.0171	CrCrCtD
Methylprednisolone—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00237	0.017	CrCrCtD
Methylprednisolone—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00237	0.017	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00237	0.017	CrCrCtD
Methylprednisolone—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00237	0.017	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00237	0.017	CrCrCtD
Methylprednisolone—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00231	0.0166	CrCrCtD
Methylprednisolone—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00226	0.0162	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00226	0.0162	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.0022	0.0158	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.0022	0.0158	CrCrCtD
Methylprednisolone—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.0022	0.0158	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.0022	0.0158	CrCrCtD
Methylprednisolone—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.0022	0.0158	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.0022	0.0158	CrCrCtD
Methylprednisolone—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00215	0.0155	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00215	0.0155	CrCrCtD
Methylprednisolone—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00215	0.0155	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.0154	CrCrCtD
Methylprednisolone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.0154	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.0154	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.0154	CrCrCtD
Methylprednisolone—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.0154	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.0021	0.0151	CrCrCtD
Methylprednisolone—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.0021	0.0151	CrCrCtD
Methylprednisolone—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.0021	0.0151	CrCrCtD
Methylprednisolone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00201	0.0145	CrCrCtD
Methylprednisolone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00193	0.0139	CrCrCtD
Methylprednisolone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00189	0.0136	CrCrCtD
Methylprednisolone—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.088	CbGpPWpGaD
Methylprednisolone—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000103	0.0778	CbGpPWpGaD
Methylprednisolone—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	8.43e-05	0.0636	CbGpPWpGaD
Methylprednisolone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	5.4e-05	0.282	CrCbGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	5.25e-05	0.0396	CbGpPWpGaD
Methylprednisolone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	5.21e-05	0.272	CrCbGaD
Methylprednisolone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	4.41e-05	0.23	CrCbGaD
Methylprednisolone—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	4.28e-05	0.0323	CbGpPWpGaD
Methylprednisolone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	3.28e-05	0.0247	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	3.26e-05	0.0246	CbGpPWpGaD
Methylprednisolone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	3.18e-05	0.000749	CcSEcCtD
Methylprednisolone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	3.18e-05	0.000749	CcSEcCtD
Methylprednisolone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	3.18e-05	0.000748	CcSEcCtD
Methylprednisolone—Syncope—Salbutamol—chronic obstructive pulmonary disease	3.17e-05	0.000747	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	3.17e-05	0.000746	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	3.17e-05	0.000746	CcSEcCtD
Methylprednisolone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.000746	CcSEcCtD
Methylprednisolone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	3.15e-05	0.000742	CcSEcCtD
Methylprednisolone—Discomfort—Formoterol—chronic obstructive pulmonary disease	3.15e-05	0.000742	CcSEcCtD
Methylprednisolone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	3.13e-05	0.000736	CcSEcCtD
Methylprednisolone—Myalgia—Montelukast—chronic obstructive pulmonary disease	3.13e-05	0.000736	CcSEcCtD
Methylprednisolone—Anxiety—Montelukast—chronic obstructive pulmonary disease	3.12e-05	0.000733	CcSEcCtD
Methylprednisolone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	3.11e-05	0.000733	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	3.1e-05	0.000731	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	3.1e-05	0.00073	CcSEcCtD
Methylprednisolone—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000726	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	3.06e-05	0.00072	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	3.06e-05	0.00072	CcSEcCtD
Methylprednisolone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	3.06e-05	0.00072	CcSEcCtD
Methylprednisolone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	3.05e-05	0.000718	CcSEcCtD
Methylprednisolone—Infection—Arformoterol—chronic obstructive pulmonary disease	3.04e-05	0.000716	CcSEcCtD
Methylprednisolone—Infection—Formoterol—chronic obstructive pulmonary disease	3.04e-05	0.000716	CcSEcCtD
Methylprednisolone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	3.01e-05	0.00071	CcSEcCtD
Methylprednisolone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	3.01e-05	0.00071	CcSEcCtD
Methylprednisolone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	3.01e-05	0.000709	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	3e-05	0.000707	CcSEcCtD
Methylprednisolone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	3e-05	0.000707	CcSEcCtD
Methylprednisolone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	3e-05	0.000706	CcSEcCtD
Methylprednisolone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	3e-05	0.000706	CcSEcCtD
Methylprednisolone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	3e-05	0.000706	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	3e-05	0.000706	CcSEcCtD
Methylprednisolone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	2.99e-05	0.000703	CcSEcCtD
Methylprednisolone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	2.99e-05	0.000703	CcSEcCtD
Methylprednisolone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	2.98e-05	0.000701	CcSEcCtD
Methylprednisolone—Infection—Montelukast—chronic obstructive pulmonary disease	2.98e-05	0.000701	CcSEcCtD
Methylprednisolone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	2.97e-05	0.0007	CcSEcCtD
Methylprednisolone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	2.97e-05	0.0007	CcSEcCtD
Methylprednisolone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	2.97e-05	0.0007	CcSEcCtD
Methylprednisolone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	2.96e-05	0.000697	CcSEcCtD
Methylprednisolone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	2.94e-05	0.000692	CcSEcCtD
Methylprednisolone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	2.93e-05	0.000691	CcSEcCtD
Methylprednisolone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	2.91e-05	0.000685	CcSEcCtD
Methylprednisolone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.000683	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	2.89e-05	0.00068	CcSEcCtD
Methylprednisolone—Infection—Salbutamol—chronic obstructive pulmonary disease	2.87e-05	0.000676	CcSEcCtD
Methylprednisolone—Hypotension—Formoterol—chronic obstructive pulmonary disease	2.86e-05	0.000673	CcSEcCtD
Methylprednisolone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	2.86e-05	0.000673	CcSEcCtD
Methylprednisolone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	2.86e-05	0.000673	CcSEcCtD
Methylprednisolone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	2.84e-05	0.00067	CcSEcCtD
Methylprednisolone—Shock—Salbutamol—chronic obstructive pulmonary disease	2.84e-05	0.000669	CcSEcCtD
Methylprednisolone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	2.84e-05	0.000668	CcSEcCtD
Methylprednisolone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	2.83e-05	0.000667	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	2.83e-05	0.000666	CcSEcCtD
Methylprednisolone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	2.82e-05	0.000664	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000663	CcSEcCtD
Methylprednisolone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	2.81e-05	0.000661	CcSEcCtD
Methylprednisolone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	2.79e-05	0.000658	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	2.79e-05	0.000658	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	2.79e-05	0.000656	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	2.79e-05	0.000656	CcSEcCtD
Methylprednisolone—Insomnia—Formoterol—chronic obstructive pulmonary disease	2.77e-05	0.000652	CcSEcCtD
Methylprednisolone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	2.77e-05	0.000652	CcSEcCtD
Methylprednisolone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	2.75e-05	0.000648	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	2.73e-05	0.000643	CcSEcCtD
Methylprednisolone—Insomnia—Montelukast—chronic obstructive pulmonary disease	2.71e-05	0.000638	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	2.7e-05	0.000636	CcSEcCtD
Methylprednisolone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	2.7e-05	0.000636	CcSEcCtD
Methylprednisolone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	2.69e-05	0.000634	CcSEcCtD
Methylprednisolone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	2.69e-05	0.000634	CcSEcCtD
Methylprednisolone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	2.69e-05	0.000634	CcSEcCtD
Methylprednisolone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	2.68e-05	0.000632	CcSEcCtD
Methylprednisolone—Injury—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000628	CcSEcCtD
Methylprednisolone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	2.66e-05	0.000626	CcSEcCtD
Methylprednisolone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	2.65e-05	0.000624	CcSEcCtD
Methylprednisolone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	2.64e-05	0.000621	CcSEcCtD
Methylprednisolone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	2.64e-05	0.000621	CcSEcCtD
Methylprednisolone—Fatigue—Formoterol—chronic obstructive pulmonary disease	2.64e-05	0.000621	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	2.63e-05	0.00062	CcSEcCtD
Methylprednisolone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	2.61e-05	0.000615	CcSEcCtD
Methylprednisolone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	2.61e-05	0.000614	CcSEcCtD
Methylprednisolone—Amnesia—Prednisone—chronic obstructive pulmonary disease	2.61e-05	0.000614	CcSEcCtD
Methylprednisolone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	2.59e-05	0.000611	CcSEcCtD
Methylprednisolone—Fatigue—Montelukast—chronic obstructive pulmonary disease	2.58e-05	0.000608	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	2.56e-05	0.000603	CcSEcCtD
Methylprednisolone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	2.56e-05	0.000602	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	2.55e-05	0.0006	CcSEcCtD
Methylprednisolone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	2.55e-05	0.0006	CcSEcCtD
Methylprednisolone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	2.54e-05	0.0192	CbGpPWpGaD
Methylprednisolone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	2.54e-05	0.000599	CcSEcCtD
Methylprednisolone—Rash—Aminophylline—chronic obstructive pulmonary disease	2.53e-05	0.000597	CcSEcCtD
Methylprednisolone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	2.53e-05	0.000596	CcSEcCtD
Methylprednisolone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	2.52e-05	0.000594	CcSEcCtD
Methylprednisolone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	2.52e-05	0.000594	CcSEcCtD
Methylprednisolone—Headache—Aminophylline—chronic obstructive pulmonary disease	2.52e-05	0.000593	CcSEcCtD
Methylprednisolone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000591	CcSEcCtD
Methylprednisolone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	2.51e-05	0.00059	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	2.5e-05	0.000589	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	2.5e-05	0.000589	CcSEcCtD
Methylprednisolone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	2.49e-05	0.000586	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	2.45e-05	0.000577	CcSEcCtD
Methylprednisolone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000577	CcSEcCtD
Methylprednisolone—Urticaria—Formoterol—chronic obstructive pulmonary disease	2.43e-05	0.000572	CcSEcCtD
Methylprednisolone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	2.43e-05	0.000572	CcSEcCtD
Methylprednisolone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	2.42e-05	0.000569	CcSEcCtD
Methylprednisolone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	2.42e-05	0.000569	CcSEcCtD
Methylprednisolone—Affect lability—Prednisone—chronic obstructive pulmonary disease	2.41e-05	0.000568	CcSEcCtD
Methylprednisolone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	2.41e-05	0.000568	CcSEcCtD
Methylprednisolone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	2.39e-05	0.000563	CcSEcCtD
Methylprednisolone—Rash—Tiotropium—chronic obstructive pulmonary disease	2.39e-05	0.000563	CcSEcCtD
Methylprednisolone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	2.39e-05	0.000562	CcSEcCtD
Methylprednisolone—Nausea—Aminophylline—chronic obstructive pulmonary disease	2.39e-05	0.000562	CcSEcCtD
Methylprednisolone—Urticaria—Montelukast—chronic obstructive pulmonary disease	2.38e-05	0.000561	CcSEcCtD
Methylprednisolone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	2.38e-05	0.000561	CcSEcCtD
Methylprednisolone—Headache—Tiotropium—chronic obstructive pulmonary disease	2.37e-05	0.000559	CcSEcCtD
Methylprednisolone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	2.37e-05	0.000559	CcSEcCtD
Methylprednisolone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	2.37e-05	0.000558	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	2.36e-05	0.000556	CcSEcCtD
Methylprednisolone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	2.34e-05	0.000552	CcSEcCtD
Methylprednisolone—Irritability—Prednisone—chronic obstructive pulmonary disease	2.34e-05	0.000551	CcSEcCtD
Methylprednisolone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	2.33e-05	0.000549	CcSEcCtD
Methylprednisolone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	2.33e-05	0.000548	CcSEcCtD
Methylprednisolone—Mood swings—Prednisone—chronic obstructive pulmonary disease	2.32e-05	0.000546	CcSEcCtD
Methylprednisolone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	2.29e-05	0.00054	CcSEcCtD
Methylprednisolone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	2.28e-05	0.000538	CcSEcCtD
Methylprednisolone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	2.25e-05	0.000531	CcSEcCtD
Methylprednisolone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	2.25e-05	0.000531	CcSEcCtD
Methylprednisolone—Nausea—Tiotropium—chronic obstructive pulmonary disease	2.25e-05	0.00053	CcSEcCtD
Methylprednisolone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	2.25e-05	0.000529	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	2.21e-05	0.0167	CbGpPWpGaD
Methylprednisolone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	2.21e-05	0.0167	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	2.21e-05	0.00052	CcSEcCtD
Methylprednisolone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	2.19e-05	0.000517	CcSEcCtD
Methylprednisolone—Asthenia—Formoterol—chronic obstructive pulmonary disease	2.19e-05	0.000517	CcSEcCtD
Methylprednisolone—Pruritus—Formoterol—chronic obstructive pulmonary disease	2.16e-05	0.00051	CcSEcCtD
Methylprednisolone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	2.16e-05	0.00051	CcSEcCtD
Methylprednisolone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	2.16e-05	0.000509	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	2.16e-05	0.000509	CcSEcCtD
Methylprednisolone—Asthenia—Montelukast—chronic obstructive pulmonary disease	2.15e-05	0.000506	CcSEcCtD
Methylprednisolone—Prednisone—ALB—chronic obstructive pulmonary disease	2.14e-05	0.112	CrCbGaD
Methylprednisolone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	2.13e-05	0.000502	CcSEcCtD
Methylprednisolone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	2.13e-05	0.000501	CcSEcCtD
Methylprednisolone—Pruritus—Montelukast—chronic obstructive pulmonary disease	2.12e-05	0.000499	CcSEcCtD
Methylprednisolone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	2.09e-05	0.000493	CcSEcCtD
Methylprednisolone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	2.09e-05	0.000493	CcSEcCtD
Methylprednisolone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	2.08e-05	0.000491	CcSEcCtD
Methylprednisolone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	2.08e-05	0.000489	CcSEcCtD
Methylprednisolone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	2.07e-05	0.000488	CcSEcCtD
Methylprednisolone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	2.06e-05	0.000486	CcSEcCtD
Methylprednisolone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	2.05e-05	0.000483	CcSEcCtD
Methylprednisolone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	2.04e-05	0.000481	CcSEcCtD
Methylprednisolone—Erythema—Prednisolone—chronic obstructive pulmonary disease	2.03e-05	0.000478	CcSEcCtD
Methylprednisolone—Dizziness—Formoterol—chronic obstructive pulmonary disease	2.02e-05	0.000476	CcSEcCtD
Methylprednisolone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	2.02e-05	0.000476	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.105	CrCbGaD
Methylprednisolone—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.0152	CbGpPWpGaD
Methylprednisolone—Dizziness—Montelukast—chronic obstructive pulmonary disease	1.98e-05	0.000467	CcSEcCtD
Methylprednisolone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	1.98e-05	0.000465	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	1.96e-05	0.0148	CbGpPWpGaD
Methylprednisolone—Vomiting—Formoterol—chronic obstructive pulmonary disease	1.95e-05	0.000458	CcSEcCtD
Methylprednisolone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	1.95e-05	0.000458	CcSEcCtD
Methylprednisolone—Rash—Arformoterol—chronic obstructive pulmonary disease	1.93e-05	0.000454	CcSEcCtD
Methylprednisolone—Rash—Formoterol—chronic obstructive pulmonary disease	1.93e-05	0.000454	CcSEcCtD
Methylprednisolone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	1.93e-05	0.000454	CcSEcCtD
Methylprednisolone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	1.93e-05	0.000454	CcSEcCtD
Methylprednisolone—Weight increased—Prednisone—chronic obstructive pulmonary disease	1.93e-05	0.000454	CcSEcCtD
Methylprednisolone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.0145	CbGpPWpGaD
Methylprednisolone—Headache—Arformoterol—chronic obstructive pulmonary disease	1.92e-05	0.000451	CcSEcCtD
Methylprednisolone—Headache—Formoterol—chronic obstructive pulmonary disease	1.92e-05	0.000451	CcSEcCtD
Methylprednisolone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	1.91e-05	0.00045	CcSEcCtD
Methylprednisolone—Vomiting—Montelukast—chronic obstructive pulmonary disease	1.91e-05	0.000449	CcSEcCtD
Methylprednisolone—Rash—Montelukast—chronic obstructive pulmonary disease	1.89e-05	0.000445	CcSEcCtD
Methylprednisolone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	1.89e-05	0.000444	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	1.88e-05	0.000444	CcSEcCtD
Methylprednisolone—Headache—Montelukast—chronic obstructive pulmonary disease	1.88e-05	0.000442	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	1.86e-05	0.000438	CcSEcCtD
Methylprednisolone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	1.85e-05	0.000437	CcSEcCtD
Methylprednisolone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	1.85e-05	0.000436	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	1.85e-05	0.000436	CcSEcCtD
Methylprednisolone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	1.85e-05	0.0139	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	1.84e-05	0.0139	CbGpPWpGaD
Methylprednisolone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	1.84e-05	0.000432	CcSEcCtD
Methylprednisolone—Malaise—Prednisolone—chronic obstructive pulmonary disease	1.83e-05	0.000431	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	1.83e-05	0.0138	CbGpPWpGaD
Methylprednisolone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	1.82e-05	0.000429	CcSEcCtD
Methylprednisolone—Rash—Salbutamol—chronic obstructive pulmonary disease	1.82e-05	0.000429	CcSEcCtD
Methylprednisolone—Syncope—Prednisolone—chronic obstructive pulmonary disease	1.82e-05	0.000429	CcSEcCtD
Methylprednisolone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	1.82e-05	0.000428	CcSEcCtD
Methylprednisolone—Nausea—Formoterol—chronic obstructive pulmonary disease	1.82e-05	0.000428	CcSEcCtD
Methylprednisolone—Nausea—Arformoterol—chronic obstructive pulmonary disease	1.82e-05	0.000428	CcSEcCtD
Methylprednisolone—Headache—Salbutamol—chronic obstructive pulmonary disease	1.81e-05	0.000426	CcSEcCtD
Methylprednisolone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	1.78e-05	0.00042	CcSEcCtD
Methylprednisolone—Nausea—Montelukast—chronic obstructive pulmonary disease	1.78e-05	0.000419	CcSEcCtD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.0134	CbGpPWpGaD
Methylprednisolone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	1.76e-05	0.000414	CcSEcCtD
Methylprednisolone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	1.75e-05	0.000413	CcSEcCtD
Methylprednisolone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	1.73e-05	0.000406	CcSEcCtD
Methylprednisolone—Nausea—Salbutamol—chronic obstructive pulmonary disease	1.72e-05	0.000404	CcSEcCtD
Methylprednisolone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	1.71e-05	0.000402	CcSEcCtD
Methylprednisolone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	1.7e-05	0.000401	CcSEcCtD
Methylprednisolone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	1.69e-05	0.000399	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	1.69e-05	0.0127	CbGpPWpGaD
Methylprednisolone—Hallucination—Prednisone—chronic obstructive pulmonary disease	1.69e-05	0.000397	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	1.67e-05	0.000392	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	1.66e-05	0.00039	CcSEcCtD
Methylprednisolone—Shock—Prednisolone—chronic obstructive pulmonary disease	1.63e-05	0.000384	CcSEcCtD
Methylprednisolone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	1.62e-05	0.000381	CcSEcCtD
Methylprednisolone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	1.61e-05	0.0121	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	1.6e-05	0.000377	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.012	CbGpPWpGaD
Methylprednisolone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	1.58e-05	0.000373	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	1.57e-05	0.0118	CbGpPWpGaD
Methylprednisolone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	1.54e-05	0.0116	CbGpPWpGaD
Methylprednisolone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	1.54e-05	0.000362	CcSEcCtD
Methylprednisolone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	1.53e-05	0.00036	CcSEcCtD
Methylprednisolone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	1.51e-05	0.000356	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	1.51e-05	0.0114	CbGpPWpGaD
Methylprednisolone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	1.5e-05	0.000353	CcSEcCtD
Methylprednisolone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	1.49e-05	0.00035	CcSEcCtD
Methylprednisolone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	1.48e-05	0.00035	CcSEcCtD
Methylprednisolone—Erythema—Prednisone—chronic obstructive pulmonary disease	1.48e-05	0.000347	CcSEcCtD
Methylprednisolone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	1.48e-05	0.000347	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	1.47e-05	0.0111	CbGpPWpGaD
Methylprednisolone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.011	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	1.4e-05	0.0105	CbGpPWpGaD
Methylprednisolone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	1.37e-05	0.000322	CcSEcCtD
Methylprednisolone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	1.37e-05	0.000321	CcSEcCtD
Methylprednisolone—Angioedema—Prednisone—chronic obstructive pulmonary disease	1.35e-05	0.000317	CcSEcCtD
Methylprednisolone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.0101	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	1.34e-05	0.0101	CbGpPWpGaD
Methylprednisolone—Malaise—Prednisone—chronic obstructive pulmonary disease	1.33e-05	0.000313	CcSEcCtD
Methylprednisolone—Vertigo—Prednisone—chronic obstructive pulmonary disease	1.33e-05	0.000312	CcSEcCtD
Methylprednisolone—Syncope—Prednisone—chronic obstructive pulmonary disease	1.32e-05	0.000312	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	1.32e-05	0.00998	CbGpPWpGaD
Methylprednisolone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	1.32e-05	0.00031	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	1.31e-05	0.00989	CbGpPWpGaD
Methylprednisolone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	1.3e-05	0.000305	CcSEcCtD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.00974	CbGpPWpGaD
Methylprednisolone—Convulsion—Prednisone—chronic obstructive pulmonary disease	1.28e-05	0.000301	CcSEcCtD
Methylprednisolone—Hypertension—Prednisone—chronic obstructive pulmonary disease	1.27e-05	0.0003	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	1.27e-05	0.00956	CbGpPWpGaD
Methylprednisolone—Myalgia—Prednisone—chronic obstructive pulmonary disease	1.26e-05	0.000296	CcSEcCtD
Methylprednisolone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	1.26e-05	0.000296	CcSEcCtD
Methylprednisolone—Anxiety—Prednisone—chronic obstructive pulmonary disease	1.25e-05	0.000295	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	1.25e-05	0.000294	CcSEcCtD
Methylprednisolone—Discomfort—Prednisone—chronic obstructive pulmonary disease	1.24e-05	0.000292	CcSEcCtD
Methylprednisolone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	1.23e-05	0.00928	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	1.22e-05	0.00924	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	1.22e-05	0.000287	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	1.22e-05	0.00919	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	1.21e-05	0.00912	CbGpPWpGaD
Methylprednisolone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	1.2e-05	0.000283	CcSEcCtD
Methylprednisolone—Infection—Prednisone—chronic obstructive pulmonary disease	1.2e-05	0.000282	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	1.19e-05	0.009	CbGpPWpGaD
Methylprednisolone—Shock—Prednisone—chronic obstructive pulmonary disease	1.18e-05	0.000279	CcSEcCtD
Methylprednisolone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	1.18e-05	0.000278	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	1.18e-05	0.00888	CbGpPWpGaD
Methylprednisolone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	1.18e-05	0.000277	CcSEcCtD
Methylprednisolone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	1.17e-05	0.000275	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	1.16e-05	0.000274	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	1.13e-05	0.0085	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	1.12e-05	0.00842	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	1.1e-05	0.000258	CcSEcCtD
Methylprednisolone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	1.1e-05	0.000258	CcSEcCtD
Methylprednisolone—Insomnia—Prednisone—chronic obstructive pulmonary disease	1.09e-05	0.000256	CcSEcCtD
Methylprednisolone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	1.08e-05	0.000255	CcSEcCtD
Methylprednisolone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	1.06e-05	0.00025	CcSEcCtD
Methylprednisolone—Rash—Prednisolone—chronic obstructive pulmonary disease	1.04e-05	0.000246	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	1.04e-05	0.000246	CcSEcCtD
Methylprednisolone—Fatigue—Prednisone—chronic obstructive pulmonary disease	1.04e-05	0.000244	CcSEcCtD
Methylprednisolone—Headache—Prednisolone—chronic obstructive pulmonary disease	1.04e-05	0.000244	CcSEcCtD
Methylprednisolone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.92e-06	0.000234	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.85e-06	0.000232	CcSEcCtD
Methylprednisolone—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.84e-06	0.000232	CcSEcCtD
Methylprednisolone—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.56e-06	0.000225	CcSEcCtD
Methylprednisolone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.52e-06	0.000224	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	9.49e-06	0.00716	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.49e-06	0.00716	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	9.02e-06	0.00681	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	8.95e-06	0.00675	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.87e-06	0.000209	CcSEcCtD
Methylprednisolone—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.64e-06	0.000203	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	8.59e-06	0.00648	CbGpPWpGaD
Methylprednisolone—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.52e-06	0.000201	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.27e-06	0.00624	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.24e-06	0.000194	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.21e-06	0.00619	CbGpPWpGaD
Methylprednisolone—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.96e-06	0.000187	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	7.88e-06	0.00594	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.85e-06	0.00592	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	7.77e-06	0.00586	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.67e-06	0.00579	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.66e-06	0.00578	CbGpPWpGaD
Methylprednisolone—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.65e-06	0.00018	CcSEcCtD
Methylprednisolone—Rash—Prednisone—chronic obstructive pulmonary disease	7.59e-06	0.000179	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.58e-06	0.000179	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.57e-06	0.00571	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	7.57e-06	0.00571	CbGpPWpGaD
Methylprednisolone—Headache—Prednisone—chronic obstructive pulmonary disease	7.54e-06	0.000178	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.32e-06	0.00552	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.32e-06	0.00552	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.28e-06	0.00549	CbGpPWpGaD
Methylprednisolone—Nausea—Prednisone—chronic obstructive pulmonary disease	7.15e-06	0.000168	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.9e-06	0.0052	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.78e-06	0.00512	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	6.55e-06	0.00494	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	6.4e-06	0.00483	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.22e-06	0.00469	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	6.18e-06	0.00466	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.71e-06	0.00431	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.58e-06	0.00421	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.5e-06	0.00415	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	5.27e-06	0.00398	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.95e-06	0.00373	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	4.82e-06	0.00364	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	4.64e-06	0.0035	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.52e-06	0.00341	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.52e-06	0.00341	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.34e-06	0.00327	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	4.25e-06	0.00321	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.19e-06	0.00316	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.02e-06	0.00303	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.98e-06	0.003	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.93e-06	0.00296	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.93e-06	0.00296	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	3.9e-06	0.00294	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	0.00277	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	3.64e-06	0.00275	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.4e-06	0.00257	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.3e-06	0.00249	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.26e-06	0.00246	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.15e-06	0.00238	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.13e-06	0.00236	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.12e-06	0.00236	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	2.94e-06	0.00222	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.92e-06	0.0022	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.76e-06	0.00208	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.72e-06	0.00205	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	0.00192	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.53e-06	0.00191	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.5e-06	0.00188	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.4e-06	0.00181	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.38e-06	0.0018	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.37e-06	0.00179	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.26e-06	0.0017	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.22e-06	0.00168	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.08e-06	0.00157	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-06	0.00152	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.93e-06	0.00146	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.88e-06	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.68e-06	0.00127	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.61e-06	0.00122	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.54e-06	0.00116	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.51e-06	0.00114	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.44e-06	0.00109	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.28e-06	0.000965	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.27e-06	0.000957	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.24e-06	0.000939	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.16e-06	0.000873	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-06	0.000833	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-06	0.000823	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.09e-06	0.00082	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.95e-07	0.000751	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.67e-07	0.00073	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.17e-07	0.000692	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.65e-07	0.000577	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.54e-07	0.000569	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.03e-07	0.00053	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.8e-07	0.000513	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.72e-07	0.000507	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.66e-07	0.000503	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.13e-07	0.000463	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.65e-07	0.000426	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.71e-07	0.000356	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.65e-07	0.000351	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.53e-07	0.000342	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.33e-07	0.000327	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.33e-07	0.000327	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.11e-07	0.00031	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.79e-07	0.000211	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.67e-07	0.000201	CbGpPWpGaD
